Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WNDM Medical was a U.S. wound-care and surgical-product company focused on commercializing products for surgical tissue repair, advanced wound care, and related skin-care applications. The business developed, marketed, and distributed biotechnology and medtech products to physicians, hospitals, clinics, and post-acute care settings, with a historical emphasis on collagen-based wound products such as CellerateRX. In 2019, WNDM Medical changed its corporate name to Sanara MedTech and continued operating as a public medical technology company. As such, WNDM Medical is best understood as the former name of the active company now known as Sanara MedTech rather than as a separate currently operating entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WNDM Medical.